UBS Group AG - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 43 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$72,105
-10.6%
5,848
-10.8%
0.00%
Q2 2023$80,676
+109.9%
6,559
+109.7%
0.00%
Q1 2023$38,443
+332.8%
3,128
+303.6%
0.00%
Q4 2022$8,882
-53.3%
775
-85.1%
0.00%
Q3 2022$19,000
+137.5%
5,196
+317.7%
0.00%
Q2 2022$8,000
-46.7%
1,244
-46.0%
0.00%
Q1 2022$15,000
+1400.0%
2,303
+1069.0%
0.00%
Q4 2021$1,0000.0%1970.0%0.00%
Q3 2021$1,000
-66.7%
197
-60.5%
0.00%
Q2 2021$3,000
-70.0%
499
-70.5%
0.00%
Q1 2021$10,000
+900.0%
1,693
+759.4%
0.00%
Q4 2020$1,0000.0%1970.0%0.00%
Q3 2020$1,0000.0%1970.0%0.00%
Q2 2020$1,000
-80.0%
197
-92.3%
0.00%
Q1 2020$5,000
+400.0%
2,550
+1194.4%
0.00%
Q4 2019$1,000
-92.3%
197
-92.8%
0.00%
Q3 2019$13,000
+225.0%
2,755
+361.5%
0.00%
Q2 2019$4,000
-71.4%
597
-71.7%
0.00%
Q1 2019$14,000
-6.7%
2,109
-46.6%
0.00%
Q4 2018$15,000
+25.0%
3,946
+78.6%
0.00%
Q3 2018$12,000
+9.1%
2,209
+5.9%
0.00%
Q2 2018$11,000
+175.0%
2,086
+303.5%
0.00%
Q1 2018$4,000
-94.3%
517
-92.4%
0.00%
Q4 2017$70,000
-33.3%
6,777
-6.6%
0.00%
Q3 2017$105,0007,2530.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders